SPOTLIGHT -
An online poll of New England Journal of Medicine readers shows a lack of consensus over prostate cancer screening, with a little over half of respondents recommending screening for a 55-year-old man.
Blue light cystoscopy improves NMIBC detection in all racial groups
"Our study showed that regardless of race, BLC increases the detection of bladder cancer when combined with WLC," says Sia Daneshmand, MD.
Health policy in urology: 2024 AUA Advocacy Summit recap
In this episode of Speaking of Urology®, Eugene Rhee, MD, MBA, and Logan Galansky, MD, discuss key topics in health policy and recap the AUA's recent Annual Urology Advocacy Summit.
Active surveillance does not increase malpractice risk across cancers
“This data should bolster physicians’ confidence in recommending active surveillance for their patients when it is an appropriate option," says Timothy J. Daskivich, MD.
Dr. Murphy on increasing diversity in cancer clinical trials
In this podcast episode, Adam B. Murphy, MD, MBA, MSCI, discusses the need to increase diversity in clinical trials, specifically focusing on studies in prostate cancer.
Urine-based assay demonstrates predictive efficacy in MIBC
The AssureMDx test demonstrated an area under the curve of 0.80 in detecting urinary tract recurrences in MIBC.
Circulating biomarkers are prognostic for radium-223 benefit in mCRPC
“These results are encouraging and suggest that circulating biomarkers may be useful in guiding the use of radium-223 therapy,” says David T. Miyamoto, MD, PhD.